Skip to main content
logo
Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1140
-0.0010 (-0.87%)
Aug 13, 2026, 1:56 PM CET

Spago Nanomedical AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
--26.94-33.71-43.07-39.47-39.19
Other Adjustments
-25.79-26.36-30.13-40.43-38.22-38.2
Changes in Other Operating Activities
--1.65-2.75-3.160.653.13
Operating Cash Flow
-25.13-28.3-34.67-44.91-38.19-35.57
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.15-0.13-0.37
Sale of Property, Plant & Equipment
-0.86-0---
Purchases of Intangible Assets
----0.35-3.7-4.25
Other Investing Activities
--0.23-0.23---
Investing Cash Flow
0.040.63-0.23-0.51-3.83-4.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
-24.8722.1528.5351.6664.21
Net Common Stock Issued (Repurchased)
-24.8722.1528.5351.6664.21
Financing Cash Flow
24.4324.8722.1528.5351.6664.21

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.66-2.8-12.75-16.889.6424.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.13-28.3-34.67-45.06-38.32-35.94
Free Cash Flow Growth
------
FCF Margin
-573.15%-586.83%-501.49%-759.77%-593.20%-550.25%
Free Cash Flow Per Share
-0.06-0.08-0.10-0.43-0.60-0.90
Levered Free Cash Flow
-25.92-28.2-35.26-45.53-38.68-36.32
Unlevered Free Cash Flow
-26.39-28.59-36.46-46.38-38.95-36.44